Bloomberg Business

Eli Lilly, Insulin Makers Sued by California Over Prices

(Bloomberg) — Eli Lilly & Co., Novo Nordisk AS and Sanofi were sued by California over insulin prices, which the state claims are inflated through unfair and deceptive practices and disproportionately affect low-income households and people of color.

Central Bank Rates Seen Peaking Soon in Southeast Asia

Southeast Asian central banks look like they are close to done fighting inflation using interest rates, with economists seeing the tightening cycle ending after 25- to 50-basis points of moves in the coming months.

Close Bitnami banner
Bitnami